Alveolar distribution of ruxolitinib in pulmonary alveolar proteinosis developing during the treatment of chronic GVHD.

Jakafi (ruxolitinib) - Incyte

Alveolar distribution of ruxolitinib in pulmonary alveolar proteinosis developing during the treatment of chronic GVHD. (PubMed, Blood Adv) - Oct 8, 2026 - No abstract available
Journal • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology • Respiratory Diseases

http://www.ncbi.nlm.nih.gov/pubmed/42842873

Daigo Hashimoto; Keiko Yasuda; Mitsuru Sugawara; Munehiro Matsumoto; Reiki Ogasawara; Shuhei Yoshikawa; Souichi Shiratori; Takanori Teshima; Yoh Takekuma; Yui Moritsugu; Yuki Tazawa

Oct 8, 2026